The expression of AML1-ETO9a isoform in acute myeloid leukemia M2 subtype and its clinical significance.

被引：0
|
作者：
Miao, Yu Q.
Chen, Zi X.
Cen, Jian N.
Yan, Ming
He, Jun
Qiu, Qiao Ch.
Zhang, Dong E.
机构：
[1] Soochow Univ, 1 Affiliated Hosp, Jiainsngsu Inst Hematol, Leukemia Unit, Suzhou, Peoples R China
[2] Scripps Res Inst, Dept Mol & Expt Med, Div Oncovirol, La Jolla, CA USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2317
引用
收藏
页码：656A / 656A
页数：1
相关论文
共 50 条
  • [21] AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations
    Yuan, YZ
    Zhou, LM
    Miyamoto, T
    Iwasaki, H
    Harakawa, N
    Hetherington, CJ
    Burel, SA
    Lagasse, E
    Weissman, IL
    Akashi, K
    Zhang, DE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) : 10398 - 10403
  • [22] AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations
    Yuan, YZ
    Zhou, LM
    Miyamoto, T
    Iwasaki, H
    Harakawa, N
    Hetherington, CJ
    Burel, SA
    Lagasse, E
    Weissman, IL
    Akashi, K
    Zhang, DE
    BLOOD, 2001, 98 (11) : 565A - 566A
  • [23] Expression and clinical significance of heat-shock proteins (HSP) in acute myeloid leukemia (AML).
    Campos, L
    Chautard, S
    Boudard, D
    Viallet, A
    Piselli, S
    Guyotat, D
    BLOOD, 1999, 94 (10) : 68A - 68A
  • [24] Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia
    Kobayashi, M.
    Chen, S.
    Bai, Y.
    Yao, C.
    Gao, R.
    Sun, X-J
    Mu, C.
    Twiggs, T. A.
    Yu, Z-H
    Boswell, H. S.
    Yoder, M. C.
    Kapur, R.
    Mulloy, J. C.
    Zhang, Z-Y
    Liu, Y.
    LEUKEMIA, 2017, 31 (06) : 1453 - 1457
  • [25] Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia
    M Kobayashi
    S Chen
    Y Bai
    C Yao
    R Gao
    X-J Sun
    C Mu
    T A Twiggs
    Z-H Yu
    H S Boswell
    M C Yoder
    R Kapur
    J C Mulloy
    Z-Y Zhang
    Y Liu
    Leukemia, 2017, 31 : 1453 - 1457
  • [26] BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2
    Niu, Yuna
    Yang, Xue
    Chen, Yifei
    Zhang, Linbo
    Jin, Xinyue
    Tang, Youjing
    Li, Li
    Yu, Lu
    Guo, Yilin
    Wang, Hui
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (02) : 541 - 548
  • [27] Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity
    Ferrara, F
    Del Vecchio, L
    HAEMATOLOGICA, 2002, 87 (03) : 306 - 319
  • [28] Expression level of CDX2 gene in acute myeloid leukemia and its clinical significance
    陆瀅
    ChinaMedicalAbstracts(InternalMedicine), 2012, 29 (04) : 232 - 232
  • [29] Characterisation and prognostic significance of WT-1 gene expression in acute myeloid leukemia (AML).
    Lane, Steven W.
    Saal, Russell
    Negus, Suzanne
    Mollee, Peter
    Mather, M.
    Gill, Devinder
    Mills, Anthony K.
    Bird, Robert J.
    Hourigan, Matthew J.
    Jones, Mark
    Marlton, Paula
    BLOOD, 2006, 108 (11) : 655A - 655A
  • [30] Prognostic significance of FLT3/ITD mutation in AML1/ETO-associated acute myeloid leukemia
    Kim, Yeo-Kyeoung
    Kim, Hee-Nam
    Lee, Il-Kwon
    Bang, Soo-Mee
    Jo, Deog-Yeon
    Won, Jong-Ho
    Yim, Chang-Yeol
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    BLOOD, 2007, 110 (11) : 1023A - 1023A
12345